Literature DB >> 28847746

17β-Hydroxysteroid dehydrogenase 3 deficiency: Three case reports and a systematic review.

Zuwei Yang1, Lei Ye1, Wei Wang2, Yu Zhao1, Wencui Wang1, Huiying Jia3, Zhiya Dong2, Yuhong Chen3, Weiqing Wang1, Guang Ning1, Shouyue Sun4.   

Abstract

17β-Hydroxysteroid dehydrogenase 3 deficiency is a rare autosomal recessive cause of 46, XY disorders of sex development resulting from HSD17B3 gene mutations, however, no case has been reported in East Asia. The aim of this study was to report three Chinese 46, XY females with 17β-HSD3 deficiency in a single center and perform a systematic review of the literature. Clinical examination, endocrine evaluation and HSD17B3 gene sequencing were performed in the three Chinese phenotypically females (two sisters and one unrelated patient). Relevant articles were searched by using the term "HSD17B3" OR "17beta-HSD3 gene" with restrictions on language (English) and species (human) in Pubmed and Embase. All the three phenotypically female subjects showed 46, XY karyotype, inguinal masses, decreased testosterone and increased androstenedione. Two novel homozygous mutations (W284X and c.124_127delTCTT) in HSD17B3 gene were identified. A systematic review found a total of 121 pedigrees/158 patients, with 78.5% (124/158) of patients assigned as females, 15.2% (24/158) from females to males, and 5.1% (8/158) raised as males. The most common mutation was c.277+4C>T (allele frequency: 25/72) for patients from Europe, and R80Q (allele frequency: 21/54) for patients from West Asia. The testicular histology showed normal infantile testicular tissue in 100% (9/9) infantile patients, normal quantity germ cells in 44.4% (8/18) prepubertal patients and 19.0% (4/21) pubertal and adult patients. We reported the first East Asian 17β-hydroxysteroid dehydrogenase 3 deficiency cases. Additional literature reviews found founder effects among patients with different ethnic background and early orchiopexy may benefit fertility in patients assigned as males. These findings may significantly expand the clinical, ethnic and genetic spectrum of 17β-hydroxysteroid dehydrogenase 3 deficiency.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  17β-Hydroxysteroid dehydrogenase 3 deficiency; 46, XY disorders of sex development; HSD17B3 gene

Mesh:

Substances:

Year:  2017        PMID: 28847746     DOI: 10.1016/j.jsbmb.2017.08.012

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

1.  Whole exome sequencing and functional characterization increase diagnostic yield in siblings with a 46, XY difference of sexual development (DSD).

Authors:  Sofia E Luna; Daniel J Wegner; Sarah Gale; Ping Yang; Abby Hollander; Lori St Dennis-Feezle; Zeina M Nabhan; Daniel S Ory; F Sessions Cole; Jennifer A Wambach
Journal:  J Steroid Biochem Mol Biol       Date:  2021-05-10       Impact factor: 5.011

2.  The Curcumin Derivative, H10, Suppresses Hormone-Dependent Prostate Cancer by Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3.

Authors:  Yating Cheng; Yan Yang; Yinan Wu; Wencheng Wang; Lichun Xiao; Yifan Zhang; Jianzhong Tang; Ya-Dong Huang; Shu Zhang; Qi Xiang
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

Review 3.  Primary Amenorrhea Due to Anatomical Abnormalities of the Reproductive Tract: Molecular Insight.

Authors:  Karina Kapczuk; Witold Kędzia
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

Review 4.  Disorder of Sex Development Due to 17-Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency: A Case Report and Review of 70 Different HSD17B3 Mutations Reported in 239 Patients.

Authors:  Catarina I Gonçalves; Josianne Carriço; Margarida Bastos; Manuel C Lemos
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.